Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ChitogenX logo — ChitogenX Inc. is dedicated to the development of novel ther...

ChitogenX

ChitogenX Inc. is dedicated to the development of novel therapeutic tissue repair technologies to improve tissue healing

Founded 2015 Canada Canada 4 employees Post-IPO Equity Total: $14.05M Biotechnology, Health Care

General Information

Company Name ChitogenX
Founded Year 2015
Location Canada Canada
Employees 4
Industries Biotechnology, Health Care
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with ChitogenX. To contact ChitogenX, visit chitogenx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ChitogenX compare?

A PDF of ChitogenX and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ChitogenX soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ChitogenX

ChitogenX Inc. is dedicated to the development of novel therapeutic tissue repair technologies to improve tissue healing. Headquartered in Kickland, Quebec, the company, formerly known as Ortho Regenerative Technologies Inc., focuses on clinical stage regenerative medicine. Their proprietary RESTORE technology platform utilizes a muco-adhesive CHITOSAN based biopolymer matrix to deliver biologics such as platelet-rich plasma (PRP) or bone marrow aspirate concentrate (BMAC) to enhance healing in musculoskeletal conditions. The company's lead product, ORTHO-R, a Chitosan-PRP hybrid biologic implant combination, aims to increase the healing rates of occupational and sports-related injuries to tendons, ligaments, and cartilage such as the meniscus. Currently undergoing a U.S. Phase I/II clinical trial for rotator cuff tear repair, this product is attracting interest from the medical community. ChitogenX is also developing other formulations to leverage the technology’s characteristics for various tissues damaged by trauma or disease. Founded in 2015, ChitogenX operates within the Biotechnology and Health Care industries. Their last investment, a $2.50M Post-IPO Equity investment, took place on April 4, 2023. The investors involved in this latest funding round are not disclosed. For more detailed information about ChitogenX, one can visit the company's website at www.chitogenx.com and find additional resources on SEDAR at www.sedar.com.

Business keywords: regenerative medicine, tissue repair, biopolymer matrix, musculoskeletal conditions, orthopedic biotechnology, clinical stage, biologics delivery, orthopedic surgery, rotator cuff tear, sports medicine, tendon injuries, ligament injuries, cartilage injuries, biomedical technology, clinical trials

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $2.50M -
04 Apr 2023
Grant $3.50M 1
Natural Sciences and Engineering Research Council of Canada (NSERC)
15 Feb 2023
Post IPO Equity $4.35M -
09 Feb 2023
Grant $500.00K 1
Axelys
Axelys
26 May 2022
Post IPO Equity $3.20M -
11 Feb 2022

ChitogenX Alternatives & Competitors

View All Alternatives
ChitogenX vs
Serica
Serica

Serica is a growth-stage medical device company focused on the development of silk-based biomaterial...

Series C
15 employees
Biotechnology, Health Care
ChitogenX vs
ORTEQ Sports Medicine
ORTEQ Sports Medicine United Kingdom

We aim to reduce patient suffering from meniscus and articular cartilage injury or degeneration by c...

Venture round
9 employees
Biotechnology, Health Care
ChitogenX vs
Artelon
Artelon United States

Leading in Dynamic Ankle Stabilization

Series B
10 employees
Biotechnology, Health Care
View all alternatives

FAQ About ChitogenX

ChitogenX Inc. is dedicated to the development of novel therapeutic tissue repair technologies to improve tissue healing
ChitogenX was founded in 2015.
ChitogenX is headquartered in Canada.
ChitogenX operates in Biotechnology and Health Care. Its work centres on regenerative medicine, tissue repair, biopolymer matrix and musculoskeletal conditions.
ChitogenX has approximately 4 employees.
ChitogenX has completed 5 funding rounds, raising a total of $14.05M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to ChitogenX include Serica, ORTEQ Sports Medicine, Artelon, Kuros Biosciences, PUR Biologics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ChitogenX and Serica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ChitogenX, https://bouncewatch.com/company/chitogenx, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes